MET and breast cancer: In addition, Busnena et al. demonstrated that in the MDA-MB231 human breast cancer cell line, ligstroside aglycone treatment showed antimigratory activity through the inhibition of c-MET signaling, without any cytotoxicity to normal cells [137].